Navigation Links
Ivy Foundation Funds New Brain Cancer Research Consortium : $3M Stage I Project Aims to Improve Personalized Medicine for Patients
Date:7/8/2008

Today, the Ben and Catherine Ivy Foundation (Ivy Foundation), a newly formed family foundation dedicated to improving survival and quality of life for patients with brain tumors, announced funding for the Ivy Genomics-Based Medicine Project.

PALO ALTO, Calif. (Business Wire EON) July 8, 2008 -- The Ivy Genomics-Based Medicine Project (Ivy G.B.M. Project) is a collaboration among nine U.S. institutions working together to try to better understand how the genetic differences in individual brain tumors can potentially inform the prediction of what will be the most effective treatment option for each patient. This project will categorize tumors by molecular profiling and, for the first time in brain cancer research, test each tumor against a wide spectrum of treatments to match differences in response with the profiles.

"Currently, all patients get basically the same treatment without taking into account the genetic profile of their tumor," said Catherine Ivy, Founder of the Ivy Foundation. "The end goal of this research initiative is to identify how tumors with different genetic features respond to a set of treatment regimens and ultimately, it is hoped, provide physicians with the tools they need to offer brain tumor patients the most effective treatment options based on the specific genetic profile of their tumor."

The $3,000,000 Ivy G.B.M Project grant was awarded to the Translational Genomics Research Institute (TGen). Under the leadership of Michael Berens, Ph.D., TGen will coordinate and manage the two-stage project spanning four to five years as well as provide their expertise in genomics based research.

Stage I of The Ivy G.B.M Project will start immediately and researchers will be working on an aggressive 18-month timeline with clear milestones and deliverables. Stage I creates a new consortium of nine academic laboratories utilizing models for predicting treatment response based on the genetic profile of a patient's tumor. Real-time collaborative linkage and project-specific communication are provided through the support of 5AM Solutions of Reston, Virginia. The successful completion of Stage I will form the basis for funding Stage II, a clinical trial for patients with recurrent GBM.

"The Ivy Foundation's fast and flexible approach to brain cancer research combined with the unique gathering of exceptional researchers from leading medical institutions across the United States is already generating several 'firsts' in brain cancer research," said Dr. Berens. "The Ivy G.B.M. Project was initiated at unprecedented speed; institutional agreements were signed in a remarkable four months and, because of the collaborative nature of the project, researchers will now be able to compare results across institutions on a diverse set of tumors and treatment regimen response patterns. The size, scope and potential impact this project will have for patients with brain cancer is simply huge."

Ivy G.B.M. Project Phase One project leaders and institutions include:


  Michael E. Berens, Ph.D.

Translational Genomics Research Institute

  --

Antonio Chiocca, M.D., Ph.D. and Sean Lawler, Ph.D.

Ohio State University

  --

Howard Colman, M.D., Ph.D.

  • University of Texas M. D. Anderson Cancer Center

  --

  • Yancey Gillespie, Ph.D.

University of Alabama at Birmingham

  --

  • David James, Ph.D.

University of California, San Francisco

  --

  • Mikkelsen, M.D.

Henry Ford Hospital

  --

Jann Sarkaria, M.D.

Mayo Clinic, Rochester, Minnesota

  --

Andrew Sloan, M.D.

Case Western Reserve University School of Medicine

  --

Craig Webb, Ph.D.

  • Andel Research Institute

"We are proud to partner with TGen and these fine institutions on a project that exemplifies what The Ivy Foundation is all about – we see data sharing among researchers and medical institutions as a necessary component to moving the field of brain cancer research forward and instrumental in getting results quickly to the patients who need them," said Catherine Ivy.

About The Ben and Catherine Ivy Foundation

  • Ivy Foundation is the nation's largest privately funded foundation dedicated to improving survival and quality of life for people diagnosed with a brain tumor. Our approach is to fund research in gliomas for improved diagnostics and treatments for patients. In its inception year, 2008, The Ivy Foundation will grant $12,000,000 to patient-focused research.

  • Ivy Foundation is committed to funding research projects which embody the concept of Patient-Focused Research. Patient-Focused Research (PFR) keeps the patient and relevant clinical issues at the center of every research project and encompasses three main components:

Exchange – Fosters collaboration between institutions and disciplines and creates an on-going, back and forth dialogue between the lab and the clinic. Urgency – Each Ivy Foundation project expedites processes to get results focused on improving the lives of patients. Personalization – PFR also addresses the genetic differences among tumors with the aim of improving diagnostics and treatments for each patient diagnosed with a brain tumor. About TGen

  • Translational Genomics Research Institute (TGen) is a non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process.


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: